Company / PP&E per Share
Corcept Therapeutics Incorporated PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.02
FY2025
5-year range
$0.00 / $0.03
FY2021-FY2025
Trend
-30.9%
vs FY2024
Sector context
#145 of 191
Health Care
What the data says
Corcept Therapeutics Incorporated's pp&e per share of $0.02 is lower than 76% of companies in the Health Care sector (FY2025). PP&E per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2023 to $0.03 in FY2024.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of +4.2%.
Improved from $0.00 to $0.02 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +44.4%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 191This company $0.02 Sector average $18.90
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 30.9% year-over-year.
- Ranks #145 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -30.9% |
| FY2024 | $0.03 | +1338.1% |
| FY2023 | $0.00 | -69.7% |
| FY2022 | $0.01 | -30.4% |
| FY2021 | $0.01 | -41.3% |
| FY2020 | $0.01 | +60.2% |
| FY2019 | $0.01 | +59.9% |
| FY2018 | $0.01 | +24.2% |
| FY2017 | $0.00 | +145.8% |
| FY2016 | $0.00 | +93.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026